MESO CIK: 1345099

Mesoblast Ltd Sponsored ADR

  • Australia
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions USD
FY21:
0.15
FY22:
0.07
FY23:
0.08
FY24:
0.09
FY25:
0.20
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.60
FY22:
0.59
FY23:
0.59
FY24:
0.58
FY25:
0.58
Total assets
Change from FY21 to FY25
billions USD
FY21:
0.74
FY22:
0.66
FY23:
0.67
FY24:
0.67
FY25:
0.78

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions USD
FY21:
0.09
FY22:
0.05
FY23:
0.04
FY24:
0.07
FY25:
0.10
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.07
FY22:
0.11
FY23:
0.13
FY24:
0.12
FY25:
0.08
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.58
FY22:
0.50
FY23:
0.50
FY24:
0.48
FY25:
0.60
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
0.74
FY22:
0.66
FY23:
0.67
FY24:
0.67
FY25:
0.78

All amounts in billions USD Data source:SEC EDGAR